Save the Date for our ECCMID 2024 Symposiums & Programme
This ECCMID 2024, deep dive into the real-world impact of molecular diagnostics on patient care, explore a 360-degree holistic view on the tackling of some of the largest threats facing healthcare systems today, and discover our unique “meet the expert” presentation opportunities.
We look forward to seeing you at ECCMID 2024. Visit your Cepheid team at Booth #C8, in-person and virtually, April 27-30 2024, Barcelona, Spain.
"Innovating rapid molecular diagnostics for infectious diseases: real world impact on patient care"
In this expert session, featuring speakers from across Europe, leading healthcare professionals will present contemporary data, meta-analysis and real-world live experience on current and emerging healthcare threats – notably the ongoing challenges of circulating respiratory viruses and ever-increasing risk of antimicrobial resistance including carbapenemases and MRSA – and novel role of diagnostics in innovating patient management, infection control and antimicrobial stewardship.
Chair: Dr. Beryl Oppenheim, Senior Director Medical Affairs, Cepheid, UK
ESCMID-appointed Chair: Dr. Mariska Leeflang, Associate Professor, Amsterdam UMC, Netherland
"Rapid multiplex PCR for respiratory viruses reduces time to result and improves clinical care: results of a systematic review and meta-analysis"
Tristan Clark, Professor and Honorary Consultant in Infectious Diseases
University Hospital Southampton NHS Foundation Trust, UK
"Management of respiratory diseases in the emergency department"
Clemens Kill, Director, Center of Emergency Medicine
Essen University, Germany
"Catching the ESKAPEs: can rapid surveillance impact our control efforts?"
Valeria Cento, Associate Professor of Microbiology
Humanitas Research Hospital, Italy
"Novel approaches to CDI patient management with rapid PCR"
Elena Reigadas, Microbiologist
Hospital Gregorio Marañón, Spain
"Tackling antimicrobial resistance in Europe: prevention through diagnostics as the best defense"
This eclectic combined presentation and panel session will bring together a healthcare professional, policy maker, economist and patient, collectively accounting for the key stakeholders and influencers in the field of antimicrobial resistance (AMR). The forum will present a unique opportunity to view the tackling of AMR holistically, from a macro, clinical, and personal perspective, analyzing the key challenges faced, practical solutions, and central role of diagnostics as our best defense against resistance.
Chair: Dr. Beryl Oppenheim, Senior Director Medical Affairs, Cepheid, UK
ESCMID-appointed Chair: Dr. Truls Leegaard, Consultant Microbiologist, Akershus University Hospital, Norway
"Tackling AMR: Economist Perspective"
Ece Ozcelik, Health Policy Analyst & Expert on AMR
Organisation for Economic Co-operation and Development (OECD), France
"Tackling AMR: Policy Maker Perspective"
Andrew Ullmann, MP
Member of German Bundestag, UNITE Network, Germany
"Tackling AMR: Clinician Perspective"
José Artur Paiva, Director Intensive Care Medicine Service
Centro Hospitalar Universitário São João, Portugal
"Tackling AMR: Patient Perspective"
Vanessa Carter, AMR Patient Survivor and One Health Advocate
The AMR Narrative, UK
Save the Date: "Meet the Expert Sessions"
Meet the Expert: Dr. Frédéric Janvier
Sunday, 28th April 2024 — Lunch time | Cepheid Booth C8
"Strategy for using Xpert® Carba-R PCR on admission of EPC-suspect patients: 2020-2023 study"
Dr. Frédéric Janvier, Chief Medical Officer (COL), Associate Professor
Val-de-Grâce Hospital, France
Meet the Expert: Dr. Jan Gorm Lisby
Monday, 29th April 2024 — Lunch time | Cepheid Booth C8
"Considerations regarding evaluation of point of care molecular tests for respiratory viruses"
Dr. Jan Gorm Lisby, Chief Consultant Dept. of Clinical Microbiology
Hvidovre Hospital, Denmark
References
CE-IVD. In Vitro Diagnostic Medical Device. May not be available in all countries.
